BC Advantage Funds
16
8M
10
4
0.38
6
- Stages of investment
- Areas of investment
Summary
The company was established in North America in Canada. The leading representative office of defined VC is situated in the North Vancouver.
The top amount of exits for fund were in 2015. Considering the real fund results, this VC is 11 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this BC Advantage Funds works on 17 percentage points more the average amount of lead investments. The common things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2007.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the BC Advantage Funds, startups are often financed by BDC Venture Capital, GrowthWorks Capital, Yaletown Partners. The meaningful sponsors for the fund in investment in the same round are GrowthWorks Capital, Discovery Capital, BDC Venture Capital. In the next rounds fund is usually obtained by Porton Group, Pangaea Ventures, Oxford Technology Management.
The fund was created by Jim Heppell.
Among the most popular fund investment industries, there are Wireless, Chemical Engineering. Among the most popular portfolio startups of the fund, we may highlight NPS, Mobidia Technology, Microvisk Technologies. For fund there is a match between the location of its establishment and the land of its numerous investments - Canada. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 16
- Lead investments
- 4
- Exits
- 6
- Follow on index
- 0.38
- Investments by industry
- Wireless (5)
- Manufacturing (4)
- Health Care (4)
- Biotechnology (3)
- iOS (3) Show 25 more
- Investments by region
-
- Canada (13)
- United Kingdom (3)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Avg. valuation at time of investment
- 500K
- Group Appearance index
- 0.81
- Avg. company exit year
- 9
- Avg. multiplicator
- 0.07
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Inimex Pharmaceuticals | 02 Jun 2008 | Biotechnology, Medical, Pharmaceutical | Early Stage Venture | 22M | British Columbia, Burnaby, Canada |
| Microvisk Technologies | 09 Sep 2010 | Health Care, Manufacturing, Medical Device | Early Stage Venture | 3M | Wales, St Asaph, United Kingdom |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.